CareLoop app
The CareLoop app sits on a patient’s smartphone linking back to a secure CareLoop platform server. We have created a dynamic framework that supports multi-content delivery, ensuring a patient’s experience is based on their clinicial need.
The app is currently available and has been robustly tested for use by people with psychosis/schizophrenia, and to support perinatal mental health in new parents.
The app is currently available and has been robustly tested for use by people with psychosis/schizophrenia, and to support perinatal mental health in new parents.
CareLoop leads to significantly faster improvement in psychotic symptoms compared to standard care
Since 2010 we have worked with patients and clinicians to demonstrate the value of digital technology in the treatment and management of psychosis/schizophrenia. Using proprietary, clinically validated assessment questionnaires, CareLoop collects real-time symptom data for use by patients and healthcare workers. Insights inform patient self-management and healthcare decision making, including safer and more effective medication management.
Predictive technology identifies escalation and risk of relapse for healthcare worker or peer intervention. Cognitive behavioural therapy (CBT) is shown to be helpful for people who have experienced a first episode of psychosis and is recommended in clinical treatment guidelines for psychosis/schizophrenia in many countries around the world. Through clinical trials proactive CBT strategies within the CareLoop app provide clinical benefit to support recovery.
Predictive technology identifies escalation and risk of relapse for healthcare worker or peer intervention. Cognitive behavioural therapy (CBT) is shown to be helpful for people who have experienced a first episode of psychosis and is recommended in clinical treatment guidelines for psychosis/schizophrenia in many countries around the world. Through clinical trials proactive CBT strategies within the CareLoop app provide clinical benefit to support recovery.
80%
of people who experience a first episode of psychosis will relapse within five years
CareLoop is proven to support perinatal mental health by screening for postnatal depression as effectively as in-person tools
CareLoop helps overcome many of the barriers of conventional health visitor delivered screening, such as limited staff time, parental unwillingness to disclose difficulties to a professional, lack of partner/father screening, and language barriers.
The lifelong costs and consequences of untreated postnatal depression (PND) are high due to impact on infants as well as parents, yet it is been shown that more than half of cases go undetected or untreated.
Using the Edinburgh Postnatal Depression Scale (EPDS), CareLoop collects daily data on parent wellbeing, helping to identifying those at risk of postnatal depression for timely intervention by a health visitor.
17%
of mums experience major depression the year after birth, although less common partners & fathers also experience postnatal depression
